Results 261 to 270 of about 95,563 (285)
Some of the next articles are maybe not open access.
Teprotumumab for Thyroid Eye Disease
International Ophthalmology Clinics, 2020Christopher J, Hwang, Kian, Eftekhari
openaire +2 more sources
The Role of Thyroid Antibodies in Thyroid Eye Disease
International Ophthalmology Clinics, 2023Rachel Shemesh +2 more
openaire +2 more sources
Teprotumumab for the Treatment of Active Thyroid Eye Disease
New England Journal of Medicine, 2020George J Kahaly +2 more
exaly
2017
When the extraocular muscles (EOMs) and orbital contents are affected in patients with clinical or subclinical thyroid disorders , a variety of terms have been used to describe the ocular condition. These include Graves’ disease, Graves’ orbitopathy, endocrine ophthalmopathy , thyroid ophthalmopathy, and thyroid eye disease (TED).
openaire +1 more source
When the extraocular muscles (EOMs) and orbital contents are affected in patients with clinical or subclinical thyroid disorders , a variety of terms have been used to describe the ocular condition. These include Graves’ disease, Graves’ orbitopathy, endocrine ophthalmopathy , thyroid ophthalmopathy, and thyroid eye disease (TED).
openaire +1 more source
Updates on the understanding and management of thyroid eye disease
Therapeutic Advances in Ophthalmology, 2021Clara J Men +2 more
exaly
2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease
Endocrinology and Metabolism Clinics of North America, 2022Thanh D Hoang, Henry B Burch
exaly
Ocular surface disease in thyroid eye disease: A narrative review
Ocular Surface, 2022Harkaran S Rana +2 more
exaly
Natural history of inflammatory and non-inflammatory dry eye in thyroid eye disease
Orbit, 2021Christopher Lo +2 more
exaly